Waksal Harlan
Insider CIK 1449008 · SNT Director · LYRA Executive Chair, Director · KDMN President, CEO, Director · FRNM
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FRNM Freenome, Inc. | C Conversion deriv | 2026-07-20 | 2026-07-29 | 30,000 | — | $0 | 0 | SEC↗ |
| FRNM Freenome, Inc. | C Conversion | 2026-07-20 | 2026-07-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| FRNM Freenome, Inc. | C Conversion deriv | 2026-07-20 | 2026-07-29 | 30,000 | — | — | 0 | SEC↗ |
| FRNM Freenome, Inc. | C Conversion | 2026-07-20 | 2026-07-29 | 30,000 | — | — | 30,000 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2024-12-09 | 2024-12-11 | 128,333 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award | 2024-03-18 | 2024-03-20 | 275,000 | — | $0 | 536,966 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | P Buy | 2023-11-10 | 2023-11-13 | 25,000 | $2.96 | $74.0K | 261,966 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 200,000 | — | $0 | 200,000 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2022-06-16 | 2022-06-21 | 953,002 | — | $0 | 953,002 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | P Buy | 2022-04-12 | 2022-04-13 | 236,966 | $4.22 | $1000.0K | 236,966 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2022-02-16 | 2022-02-18 | 520,000 | — | $0 | 520,000 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | D To issuer deriv | 2021-11-09 | 2021-11-09 | 1,350,000 | $5.35 | $7.22M | 0 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | D To issuer deriv | 2021-11-09 | 2021-11-09 | 2,000,000 | $5.54 | $11.08M | 0 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | D To issuer deriv | 2021-11-09 | 2021-11-09 | 750 | $3.50 | $2.6K | 0 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | D To issuer deriv | 2021-11-09 | 2021-11-09 | 982,500 | $5.44 | $5.34M | 0 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | D To issuer deriv | 2021-11-09 | 2021-11-09 | 655,000 | $5.86 | $3.84M | 0 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | D To issuer | 2021-11-09 | 2021-11-09 | 177,945 | $9.50 | $1.69M | 0 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award | 2021-05-13 | 2021-05-17 | 25,000 | $3.56 | $89.0K | 177,945 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award deriv | 2021-04-03 | 2021-04-06 | 327,498 | — | $0 | 982,500 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award deriv | 2021-01-08 | 2021-01-12 | 2,000,000 | — | $0 | 2,000,000 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award deriv | 2020-09-10 | 2020-09-10 | 109,167 | — | $0 | 655,002 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | P Buy | 2020-03-13 | 2020-03-16 | 16,000 | $2.93 | $46.9K | 152,945 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | P Buy | 2020-03-11 | 2020-03-11 | 12,600 | $3.96 | $49.9K | 136,945 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award deriv | 2019-11-19 | 2019-11-19 | 1,350,000 | — | $0 | 1,350,000 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award deriv | 2019-11-19 | 2019-11-19 | 1,350,000 | — | $0 | 1,350,000 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award deriv | 2019-10-24 | 2019-10-24 | 109,167 | — | $0 | 545,835 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award deriv | 2019-09-10 | 2019-09-10 | 109,167 | — | $0 | 436,668 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award deriv | 2019-06-14 | 2019-06-14 | 109,167 | — | $0 | 327,501 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award deriv | 2019-04-03 | 2019-04-05 | 218,334 | — | $0 | 218,334 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award | 2019-03-29 | 2020-03-11 | 7,716 | $2.25 | $17.4K | 124,345 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award | 2018-09-28 | 2020-03-11 | 5,882 | $2.84 | $16.7K | 116,629 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award deriv | 2017-12-08 | 2017-12-12 | 655,000 | — | $0 | 655,000 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | P Buy | 2017-08-10 | 2017-08-10 | 5,000 | $2.27 | $11.3K | 110,747 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | P Buy | 2017-08-08 | 2017-08-08 | 3,707 | $2.34 | $8.7K | 105,747 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | P Buy | 2016-11-16 | 2016-11-16 | 2,000 | $6.37 | $12.7K | 102,040 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | P Buy | 2016-11-14 | 2016-11-14 | 2,000 | $6.79 | $13.6K | 100,040 | SEC↗ |
| SVON Sevion Therapeutics, Inc. | A Award deriv | 2015-11-19 | 2015-11-23 | 40,000 | $0.25 | $10.0K | 40,000 | SEC↗ |
| SVON Sevion Therapeutics, Inc. | A Award deriv | 2015-05-18 | 2015-05-20 | 11,340 | $0.97 | $11.0K | 147,693 | SEC↗ |
| SVON Sevion Therapeutics, Inc. | A Award deriv | 2015-02-19 | 2015-02-23 | 26,552 | $0.54 | $14.3K | 136,353 | SEC↗ |
| SVON Sevion Therapeutics, Inc. | A Award deriv | 2014-11-18 | 2014-11-20 | 17,168 | $0.42 | $7.2K | 109,500 | SEC↗ |
| SVON Sevion Therapeutics, Inc. | A Award deriv | 2014-11-18 | 2014-11-20 | 38,034 | — | $0 | 92,332 | SEC↗ |
| SNTI SENESCO TECHNOLOGIES INC | A Award deriv | 2014-05-14 | 2014-05-16 | 21,932 | — | $0 | 54,298 | SEC↗ |
| SNTI SENESCO TECHNOLOGIES INC | A Award deriv | 2013-09-13 | 2013-09-16 | 530,000 | — | $0 | 3,236,572 | SEC↗ |
| SNTI SENESCO TECHNOLOGIES INC | A Award deriv | 2013-09-13 | 2013-09-24 | 530,000 | — | $0 | 3,236,572 | SEC↗ |
| SNTI SENESCO TECHNOLOGIES INC | A Award deriv | 2013-05-17 | 2013-05-20 | 273,256 | — | $0 | 2,716,572 | SEC↗ |
| SNTI SENESCO TECHNOLOGIES INC | A Award deriv | 2013-02-19 | 2013-02-20 | 145,834 | — | $0 | 2,433,316 | SEC↗ |
| SNT SENESCO TECHNOLOGIES INC | A Award deriv | 2012-11-16 | 2012-11-16 | 165,152 | — | $0 | 2,287,482 | SEC↗ |
| SNT SENESCO TECHNOLOGIES INC | A Award deriv | 2012-11-16 | 2012-11-16 | 420,000 | — | $0 | 2,122,330 | SEC↗ |
| SNT SENESCO TECHNOLOGIES INC | C Conversion deriv | 2012-08-08 | 2012-10-05 | 200 | — | $0 | 0 | SEC↗ |
| SNT SENESCO TECHNOLOGIES INC | C Conversion | 2012-08-08 | 2012-10-05 | 858,517 | $0.26 | $223.2K | 2,805,750 | SEC↗ |
| SNT SENESCO TECHNOLOGIES INC | A Award deriv | 2012-05-16 | 2012-05-18 | 46,342 | — | $0 | 1,702,330 | SEC↗ |
| SNT SENESCO TECHNOLOGIES INC | A Award deriv | 2012-02-16 | 2012-02-24 | 45,834 | — | $0 | 1,655,988 | SEC↗ |
| SNT SENESCO TECHNOLOGIES INC | P Buy | 2012-01-06 | 2012-01-19 | 961,538 | $0.26 | $250.0K | 1,902,590 | SEC↗ |